Advanced Medical Solutions(AIM: AMS): all going to plan
The global medical technology company announced a reassuring update on trading prior to its close period for the year ending 31 December 2009.
The Chairman reported that AMS has had a strong second half of the year and that the Board expects full year earnings to be in line with market expectations.
Sales of its LiquiBand™ topical skin adhesive product has has begun in the US market. Whilst FDA approval is still under review for LiquiBand™ products with specific applications in the operating room, current budgets are covered by the products already approved.
The integration of the…
Previous article Next article
